AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 19025535 — intervention group
Group type: COMPARATOR
Intervention: Ropivacaine alone (without midazolam)
Number of subjects: 60
Study 15908647 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxorubicin-cyclophosphamide (AC) neoadjuvant chemotherapy (n = 24)
Number of subjects: 48
Study 15908647 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxorubicin-docetaxel (AD) neoadjuvant chemotherapy (n = 24)
Number of subjects: 48
Study 15908647 — intervention group
Group type: COMPARATOR
Intervention: Comparison of pretreatment biopsy and tumor excised after chemotherapy
Number of subjects: 48
Study 12935395 — intervention group
Group type: EXPERIMENTAL
Intervention: Leflunomide at 20 mg once daily
Number of subjects: 566
Study 12935395 — intervention group
Group type: COMPARATOR
Intervention: Methotrexate (MTX) at 15 mg once weekly
Number of subjects: 566
Study 12935395 — intervention group
Group type: EXPERIMENTAL
Intervention: Leflunomide
Number of subjects: 566
Study 11214769 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol 12.5 mg/day for 2 days and then 25 mg/day for 5 days
Number of subjects: 22
Study 11214769 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 11214769 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 22
Study 8090376 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E supplementation
Number of subjects: 0
Study 8090376 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-carotene supplementation
Number of subjects: 0
Study 8090376 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 2680994 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 mg mesterolone daily
Number of subjects: 157
Study 2680994 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 mg mesterolone daily
Number of subjects: 157
Study 2680994 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 157
Study 781228 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenoprofen (200 to 800 mg every six hours, median daily dose 1.8 gm)
Number of subjects: 30
Study 781228 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 28470086 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent Management Training - Oregon Model (PMTO)
Number of subjects: 353
Study 28470086 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Parent Training (BPT)
Number of subjects: 353
Study 28470086 — intervention group
Group type: COMPARATOR
Intervention: Both PMTO and BPT
Number of subjects: 353
Study 28010884 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumbar cistern drainage combined with intrathecal injection of antibiotics (LCD-ITI)
Number of subjects: 60
Study 28010884 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 60
Study 26258455 — intervention group
Group type: EXPERIMENTAL
Intervention: Nintendo Wii (NW)
Number of subjects: 30
Study 26258455 — intervention group
Group type: COMPARATOR
Intervention: Conventional Physical Therapy (CPT)
Number of subjects: 30
Study 26258455 — intervention group
Group type: EXPERIMENTAL
Intervention: Both NW and CPT
Number of subjects: 30
Study 23665469 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetylsalicylic acid (ASA) 150mg daily
Number of subjects: 126
Study 23665469 — intervention group
Group type: COMPARATOR
Intervention: Acetylsalicylic acid (ASA) 75mg daily
Number of subjects: 126
Study 20224326 — intervention group
Group type: EXPERIMENTAL
Intervention: Meta-analysis of high-quality randomized-controlled trials
Number of subjects: 0
Study 19057373 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine citrate 5 mg/kg/d
Number of subjects: 110
Study 19057373 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine citrate 20 mg/kg/d
Number of subjects: 110
Study 19057373 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine citrate (both dosages)
Number of subjects: 110
Study 16619180 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral poliovirus vaccine (OPV)
Number of subjects: 140
Study 16619180 — intervention group
Group type: COMPARATOR
Intervention: Inactivated poliovirus vaccine (IPV)
Number of subjects: 140
Study 16619180 — intervention group
Group type: COMPARATOR
Intervention: Unimmunized infants
Number of subjects: 140
Study 14668503 — intervention group
Group type: EXPERIMENTAL
Intervention: Point Contact Fixator (PC‐Fix)
Number of subjects: 92
Study 14668503 — intervention group
Group type: EXPERIMENTAL
Intervention: Limited Contact Dynamic Compression Plate (LC‐DCP)
Number of subjects: 92
Study 14668503 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 92
Study 10921433 — intervention group
Group type: EXPERIMENTAL
Intervention: Compliance with the smokeless tobacco policy during competition
Number of subjects: 5000
Study 10921433 — intervention group
Group type: EXPERIMENTAL
Intervention: Compliance with the smokeless tobacco policy during practices
Number of subjects: 5000
Study 10921433 — intervention group
Group type: EXPERIMENTAL
Intervention: Perception of policy contributing to decline in overall tobacco consumption
Number of subjects: 5000
Study 9431897 — intervention group
Group type: EXPERIMENTAL
Intervention: Liquid meal (220 kJ)
Number of subjects: 30
Study 9431897 — intervention group
Group type: EXPERIMENTAL
Intervention: Semisolid meal (1472 kJ)
Number of subjects: 30
Study 1494127 — intervention group
Group type: EXPERIMENTAL
Intervention: Real occlusal adjustment
Number of subjects: 51
Study 1494127 — intervention group
Group type: COMPARATOR
Intervention: Mock occlusal adjustment
Number of subjects: 51
Study 3800700 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3 M sodium hydroxide
Number of subjects: 40
Study 3800700 — intervention group
Group type: COMPARATOR
Intervention: Reverse ultrafiltration
Number of subjects: 40
Study 3800700 — intervention group
Group type: COMPARATOR
Intervention: 3% hydrogen peroxide
Number of subjects: 40
Study 3800700 — intervention group
Group type: COMPARATOR
Intervention: Water flush
Number of subjects: 40
Study 3800700 — intervention group
Group type: EXPERIMENTAL
Intervention: NaOH
Number of subjects: 40
Study 3800700 — intervention group
Group type: COMPARATOR
Intervention: Other methods (reverse ultrafiltration, 3% hydrogen peroxide, water flush)
Number of subjects: 40
Study 31150120 — intervention group
Group type: EXPERIMENTAL
Intervention: Nimotuzumab plus cisplatin chemoradiotherapy (NCRT)
Number of subjects: 536
Study 31150120 — intervention group
Group type: COMPARATOR
Intervention: Cisplatin chemoradiotherapy alone (CRT)
Number of subjects: 536
Study 27596682 — intervention group
Group type: EXPERIMENTAL
Intervention: Submerged implants (n=30)
Number of subjects: 90
Study 27596682 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-submerged with esthetic healing abutment (n=30)
Number of subjects: 90
Study 27596682 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-submerged with anatomical healing abutment (n=30)
Number of subjects: 90
Study 25877514 — intervention group
Group type: EXPERIMENTAL
Intervention: Social‐cognitive theory‐guided oral hygiene intervention (three face‐to‐face educational hands‐on sessions facilitated by a dentist)
Number of subjects: 197
Study 25877514 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 197
Study 24643752 — intervention group
Group type: EXPERIMENTAL
Intervention: New back school program (muscular physiological characteristics)
Number of subjects: 56
Study 24643752 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy individuals)
Number of subjects: 56
Study 22992965 — intervention group
Group type: EXPERIMENTAL
Intervention: Galanthamine
Number of subjects: 45
Study 22992965 — intervention group
Group type: COMPARATOR
Intervention: Neostigmine
Number of subjects: 45
Study 20488908 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous vertebroplasty (PV)
Number of subjects: 202
Study 20488908 — intervention group
Group type: COMPARATOR
Intervention: Conservative therapy
Number of subjects: 202
Study 18068442 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand-assisted laparoscopic radical nephrectomy (HALN)
Number of subjects: 21
Study 18068442 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic radical nephrectomy (LRN)
Number of subjects: 21
Study 16164475 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupressure therapy
Number of subjects: 52
Study 16164475 — intervention group
Group type: COMPARATOR
Intervention: Massage treatment and handholding (Control)
Number of subjects: 52
Study 12098616 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine (0.1 mg/kg)
Number of subjects: 12
Study 12098616 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine (0.1 mg/kg followed by 4 microg/kg/min)
Number of subjects: 12
Study 12098616 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of morphine and ketamine
Number of subjects: 12
Study 12098616 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 12098616 — intervention group
Group type: COMPARATOR
Intervention: Ketamine
Number of subjects: 12
Study 12098616 — intervention group
Group type: COMPARATOR
Intervention: Morphine
Number of subjects: 12
Study 10398973 — intervention group
Group type: EXPERIMENTAL
Intervention: LumenHance (manganese chloride-based oral contrast agent)
Number of subjects: 217
Study 10398973 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 217
Study 8833187 — intervention group
Group type: COMPARATOR
Intervention: Sea Level (SL)
Number of subjects: 14
Study 8833187 — intervention group
Group type: EXPERIMENTAL
Intervention: Canberra (CB)
Number of subjects: 14
Study 1702939 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteral nutrition administered by needle‐catheter jejunostomy
Number of subjects: 12
Study 1702939 — intervention group
Group type: COMPARATOR
Intervention: Parenteral nutrition administered by total parenteral nutrition
Number of subjects: 12
Study 6343656 — intervention group
Group type: COMPARATOR
Intervention: Normal-sodium diet
Number of subjects: 476
Study 6343656 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-sodium diet
Number of subjects: 476
Study 31322833 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical splenectomy
Number of subjects: 0
Study 31322833 — intervention group
Group type: COMPARATOR
Intervention: Nonsurgical (control)
Number of subjects: 0
Study 30693888 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic ultrasound and jaw opening exercises
Number of subjects: 20
Study 30693888 — intervention group
Group type: COMPARATOR
Intervention: Jaw opening exercises
Number of subjects: 20
Study 30693888 — intervention group
Group type: COMPARATOR
Intervention: Comparison between experimental and control groups
Number of subjects: 20
Study 26227112 — intervention group
Group type: EXPERIMENTAL
Intervention: Health Coaching (HC) intervention delivered by a Health Coach
Number of subjects: 261
Study 26227112 — intervention group
Group type: COMPARATOR
Intervention: Education Alone (EA) group
Number of subjects: 261
Study 23740226 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous golimumab 50 mg monthly for 6 months
Number of subjects: 3366
Study 23740226 — intervention group
Group type: COMPARATOR
Intervention: Intravenous plus subcutaneous golimumab
Number of subjects: 3366
Study 23740226 — intervention group
Group type: COMPARATOR
Intervention: Subcutaneous golimumab
Number of subjects: 3366
Study 22852834 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-administered Tobacco Tactics intervention
Number of subjects: 6
Study 22852834 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 6
Study 20823391 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifactorial intervention including pill counting, family support, and educational information.
Number of subjects: 877
Study 20823391 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care).
Number of subjects: 877
Study 20823391 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifactorial intervention.
Number of subjects: 877
Study 18634504 — intervention group
Group type: EXPERIMENTAL
Intervention: YU BHK Rabivak vaccine candidate
Number of subjects: 164
Study 18634504 — intervention group
Group type: COMPARATOR
Intervention: Rabipur (commercially available vaccine)
Number of subjects: 164
Study 15805799 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidant therapy (specifics not provided)
Number of subjects: 0
Study 15805799 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E and vitamin C supplementation
Number of subjects: 0
Study 15805799 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin and coenzyme Q
Number of subjects: 0
Study 15805799 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine
Number of subjects: 0
Study 15805799 — intervention group
Group type: EXPERIMENTAL
Intervention: Other combinations of antioxidant therapies
Number of subjects: 0
Study 12394560 — intervention group
Group type: EXPERIMENTAL
Intervention: Energy Conservation and Activity Management (ECAM) intervention, 3 telephone sessions
Number of subjects: 0
Study 12394560 — intervention group
Group type: COMPARATOR
Intervention: Standard care for cancer treatment-related fatigue
Number of subjects: 0
Study 10426707 — intervention group
Group type: EXPERIMENTAL
Intervention: High energy density, low viscosity (HD-LV)
Number of subjects: 0
Study 10426707 — intervention group
Group type: EXPERIMENTAL
Intervention: Low energy density, low viscosity (LD-LV)
Number of subjects: 0
Study 10426707 — intervention group
Group type: COMPARATOR
Intervention: High energy density, high viscosity (HD-HV)
Number of subjects: 0
Study 7562086 — intervention group
Group type: EXPERIMENTAL
Intervention: Feeding status (fed state) with 13C-labeled algae (Spirulina platensis)
Number of subjects: 4
Study 7562086 — intervention group
Group type: COMPARATOR
Intervention: Fasting (fasted state)
Number of subjects: 4
Study 2188451 — intervention group
Group type: EXPERIMENTAL
Intervention: Stapler instrument for hysterotomy
Number of subjects: 100
Study 2188451 — intervention group
Group type: COMPARATOR
Intervention: Standard technique (control)
Number of subjects: 100
Study 369348 — intervention group
Group type: EXPERIMENTAL
Intervention: Right heart catheterization via antecubital venous cutdown procedure
Number of subjects: 57
Study 369348 — intervention group
Group type: COMPARATOR
Intervention: Right heart catheterization via percutaneous femoral vein approach
Number of subjects: 57
Study 30782955 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% chlorhexidine gluconate aqueous
Number of subjects: 100
Study 30782955 — intervention group
Group type: COMPARATOR
Intervention: 2% chlorhexidine gluconate in 70% isopropyl alcohol
Number of subjects: 100
Study 27612588 — intervention group
Group type: EXPERIMENTAL
Intervention: Doula support
Number of subjects: 70
Study 27612588 — intervention group
Group type: COMPARATOR
Intervention: Routine care (Control)
Number of subjects: 70
Study 26484700 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal transcranial direct current stimulation (tDCS)
Number of subjects: 12
Study 26484700 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 12
Study 25509922 — intervention group
Group type: EXPERIMENTAL
Intervention: Gepatomax Forte in conjunction with basal therapy for 4 weeks
Number of subjects: 0
Study 25509922 — intervention group
Group type: COMPARATOR
Intervention: Basal therapy only for 4 weeks
Number of subjects: 0
Study 22231536 — intervention group
Group type: EXPERIMENTAL
Intervention: Mild hypothermic CPB (32 °C)
Number of subjects: 60
Study 22231536 — intervention group
Group type: COMPARATOR
Intervention: Normothermic CPB (37 °C)
Number of subjects: 60
Study 22231536 — intervention group
Group type: COMPARATOR
Intervention: Comparison between mild hypothermic and normothermic CPB
Number of subjects: 60
Study 20667604 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboplatin chemotherapy (3-4 courses)
Number of subjects: 10
Study 20667604 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboplatin chemotherapy (higher doses)
Number of subjects: 10
Study 20667604 — intervention group
Group type: COMPARATOR
Intervention: Baseline measurement (before chemotherapy)
Number of subjects: 10
Study 17227394 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive MobiTed system
Number of subjects: 57
Study 17227394 — intervention group
Group type: COMPARATOR
Intervention: Conventional multiple choice test
Number of subjects: 57
Study 17227394 — intervention group
Group type: EXPERIMENTAL
Intervention: Native speaking students
Number of subjects: 57
Study 15110130 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin 40 mg
Number of subjects: 253
Study 11260540 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporine (Neoral) treatment until clearance or for a maximum of 12 weeks, followed by randomization into two groups: Group A (stop abruptly) and Group B (taper dose by 1 mg/kg per day until cessation within 4 weeks)
Number of subjects: 76
Study 11260540 — intervention group
Group type: COMPARATOR
Intervention: Cyclosporine (Neoral) treatment
Number of subjects: 76
Study 9652881 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose nitroglycerin patches (5 mg/24 h each)
Number of subjects: 11
Study 9652881 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 8093138 — intervention group
Group type: EXPERIMENTAL
Intervention: Cranberry beverage (300 mL per day)
Number of subjects: 153
Study 8093138 — intervention group
Group type: COMPARATOR
Intervention: Control (synthetic placebo drink)
Number of subjects: 153
Study 3147901 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxyntomodulin (100 ng kg‐1 h‐1)
Number of subjects: 6
Study 3147901 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxyntomodulin (400 ng kg‐1 h‐1)
Number of subjects: 6
Study 3147901 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxyntomodulin infusion
Number of subjects: 6
Study 29260471 — intervention group
Group type: EXPERIMENTAL
Intervention: EPPM-based mobile phone text message intervention for 2 months
Number of subjects: 130
Study 29260471 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 130
Study 27541044 — intervention group
Group type: EXPERIMENTAL
Intervention: Three true sessions of 10 Hz rTMS
Number of subjects: 98
Study 27541044 — intervention group
Group type: COMPARATOR
Intervention: One true and two sham rTMS sessions
Number of subjects: 98
Study 24132705 — intervention group
Group type: EXPERIMENTAL
Intervention: Compound Amlodipine Tablets with high-fat breakfast
Number of subjects: 12
Study 24132705 — intervention group
Group type: COMPARATOR
Intervention: Compound Amlodipine Tablets with overnight fast
Number of subjects: 12
Study 23531328 — intervention group
Group type: EXPERIMENTAL
Intervention: EPA-rich fish oil (1060 mg EPA plus 274 mg DHA)
Number of subjects: 126
Study 23531328 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA-rich fish oil (900 mg DHA plus 180 mg EPA)
Number of subjects: 126
Study 23531328 — intervention group
Group type: COMPARATOR
Intervention: Soy oil placebo
Number of subjects: 126
Study 23531328 — intervention group
Group type: EXPERIMENTAL
Intervention: EPA-rich fish oil
Number of subjects: 126
Study 23531328 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA-rich fish oil
Number of subjects: 126
Study 23531328 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum DHA concentrations at 34‐36 weeks
Number of subjects: 126
Study 20193646 — intervention group
Group type: COMPARATOR
Intervention: Continuation pharmacologic intervention (C-PHARM) with nortriptyline plus lithium for 24 weeks
Number of subjects: 85
Study 20193646 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuation electroconvulsive therapy (C-ECT) with 10 treatments
Number of subjects: 85
Study 20193646 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 85
Study 19013293 — intervention group
Group type: EXPERIMENTAL
Intervention: Triiodothyronine (T(3)) at doses of 50 to 75 microg/d
Number of subjects: 14
Study 19013293 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 19013293 — intervention group
Group type: EXPERIMENTAL
Intervention: Triiodothyronine (T(3))
Number of subjects: 14
Study 19013293 — intervention group
Group type: EXPERIMENTAL
Intervention: Triiodothyronine (T(3)) and Placebo
Number of subjects: 14
Study 16188778 — intervention group
Group type: EXPERIMENTAL
Intervention: Breastfeeding counselling by lay counsellors during home visits on days 5, 15, 30, 60, 90, and 120 after birth
Number of subjects: 1003
Study 16188778 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 1003
Study 16188778 — intervention group
Group type: EXPERIMENTAL
Intervention: Breastfeeding counselling by lay counsellors
Number of subjects: 1003
Study 12618690 — intervention group
Group type: EXPERIMENTAL
Intervention: Subfascial endoscopic perforating vein surgery (SEPS)
Number of subjects: 832
Study 12618690 — intervention group
Group type: EXPERIMENTAL
Intervention: Saphenous vein ligation and stripping
Number of subjects: 832
Study 12618690 — intervention group
Group type: EXPERIMENTAL
Intervention: SEPS
Number of subjects: 832
Study 12618690 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeat SEPS
Number of subjects: 832
Study 12618690 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep valve repair
Number of subjects: 832
Study 12618690 — intervention group
Group type: COMPARATOR
Intervention: Complications
Number of subjects: 832
Study 10587038 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenretinide for the prevention of contralateral breast cancer
Number of subjects: 1815
Study 10587038 — intervention group
Group type: COMPARATOR
Intervention: Retrospective recruitment strategy
Number of subjects: 1815
Study 10587038 — intervention group
Group type: COMPARATOR
Intervention: Prospective recruitment strategy
Number of subjects: 1815
Study 8921055 — intervention group
Group type: EXPERIMENTAL
Intervention: Highly purified human follicle‐stimulating hormone (FSH‐HP), administered s.c. (n = 19)
Number of subjects: 41
Study 8921055 — intervention group
Group type: COMPARATOR
Intervention: Human menopausal gonadotrophin (HMG), administered i.m. (n = 20)
Number of subjects: 41
Study 1884733 — intervention group
Group type: EXPERIMENTAL
Intervention: Dipyrone 1 g
Number of subjects: 451
Study 1884733 — intervention group
Group type: EXPERIMENTAL
Intervention: Dipyrone 2 g
Number of subjects: 451
Study 1884733 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac sodium
Number of subjects: 451
Study 1884733 — intervention group
Group type: EXPERIMENTAL
Intervention: Pethidine
Number of subjects: 451
Study 6412384 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium cromoglycate
Number of subjects: 20
Study 6412384 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketotifen
Number of subjects: 20